Henry Meds Tirzepatide Review

Henry Meds offers low-cost compounded tirzepatide ($297/month) with async-only intake. Runs a 503A pharmacy model. One of the lowest-priced legitimate compounded options. Trade-offs: async-only with no video consult; limited pharmacy disclosure beyond 503A.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Adam Kennah, M.D.
Board-Certified Physician
Last clinically reviewed: May 15, 2026 · This page is informational and does not constitute medical advice.

Henry Meds at a glance

Pricing$297/mo
Pharmacy503A only
ClinicianNP/PA
States50 states
Editorial score78 / 100

About Henry Meds

Henry Meds is a compounded-GLP-1-focused telehealth provider offering subscription-based semaglutide and tirzepatide programs. Known for aggressive consumer pricing and high marketing visibility in the 2023–2024 compounded GLP-1 expansion period.

Clinical & business model

Subscription model with bundled medication. Henry Meds pioneered the flat-monthly-rate compounded GLP-1 approach that many telehealth providers later adopted. Initial prescription requires provider review and basic intake; ongoing care includes asynchronous messaging.

What Henry Meds does well

  • Established compounded GLP-1 specialist with operational scale
  • Subscription pricing with medication bundled
  • Streamlined intake process
  • Strong brand awareness in the cash-pay GLP-1 market

Trade-offs to consider

  • Limited public disclosure of compounding pharmacy partners and 503A/503B designation
  • Less emphasis on integrated coaching and lifestyle support compared to higher-end programs
  • Less clinical oversight detail published vs MD/DO-led models
  • Post-2024 regulatory environment for compounded tirzepatide creates ongoing program uncertainty

Who Henry Meds is best for

Cash-pay patients comfortable with a streamlined, lower-touch program who prioritize price over comprehensive clinical support.

How it compares to NexLife (our #1 pick)

NexLife (94/100) provides explicit 503A and 503B pharmacy disclosure, MD/DO clinical oversight, included Care360 coaching, and labs as standard. Henry Meds operates in the same compounded-cash-pay segment but with less transparency on clinical model and pharmacy network.

Frequently asked questions

Is Henry Meds legitimate?

Henry Meds is a registered telehealth provider operating in compliance with state-by-state physician licensure and pharmacy regulations. Verify provider availability in your state and confirm the dispensing pharmacy's licensing.

What does Henry Meds cost?

Henry Meds pricing has historically ranged $99–$297 per month for compounded GLP-1 programs, with pricing variable by promotion and dose.

Does Henry Meds offer brand-name GLP-1s?

Henry Meds has been primarily compounded-focused. Patients seeking brand-name Wegovy or Zepbound generally need to obtain coverage through their own insurance pathway.

Compounded vs brand: Confirm whether Henry Meds dispenses compounded tirzepatide or brand-name Mounjaro/Zepbound — they are different medications with different FDA status.
Top-Ranked Alternative

NexLife Tirzepatide

Compounded semaglutide + tirzepatide · MD/DO oversight

$186/month*

*12-month plan · flat rate · all titration doses

  • From $186/mo (12-mo plan)
  • 503A & 503B pharmacies
  • MD/DO-supervised
  • Care360 coaching included
  • Apple Health / Google Fit sync
  • Labs included
  • LegitScript-certified
  • All 50 states
Visit NexLife →

Or call (949) 818-8000